» Articles » PMID: 28816147

Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy

Overview
Specialties Oncology
Radiology
Date 2017 Aug 18
PMID 28816147
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Four-dimensional (4D) computed tomography (CT) ventilation imaging is increasingly being used to calculate lung ventilation and implement functional-guided radiation therapy in clinical trials. There has been little exhaustive work evaluating which dose-function metrics should be used for treatment planning and plan evaluation. The purpose of our study was to evaluate which dose-function metrics best predict for radiation pneumonitis (RP).

Methods And Materials: Seventy lung cancer patients who underwent 4D CT imaging and pneumonitis grading were assessed. Pretreatment 4D CT scans of each patient were used to calculate ventilation images. We evaluated 3 types of dose-function metrics that combined the patient's 4D CT ventilation image and treatment planning dose distribution: (1) structure-based approaches; (2) image-based approaches using the dose-function histogram; and (3) nonlinear weighting schemes. Log-likelihood methods were used to generate normal tissue complication probability models predicting grade 3 or higher (ie, grade 3+) pneumonitis for all dose-function schemes. The area under the curve (AUC) was used to assess the predictive power of the models. All techniques were compared with normal tissue complication probability models based on traditional, total lung dose metrics.

Results: The most predictive models were structure-based approaches that focused on the volume of functional lung receiving ≥20 Gy (AUC, 0.70). Probabilities of grade 3+ RP of 20% and 10% correspond to V20 (percentage of volume receiving ≥20 Gy) to the functional subvolumes of 26.8% and 9.3%, respectively. Imaging-based analysis with the dose-function histogram and nonlinear weighted ventilation values yielded AUCs of 0.66 and 0.67, respectively, when we evaluated the percentage of functionality receiving ≥20 Gy. All dose-function metrics outperformed the traditional dose metrics (mean lung dose, AUC of 0.55).

Conclusions: A full range of dose-function metrics and functional thresholds was examined. The calculated AUC values for the most predictive functional models occupied a narrow range (0.66-0.70), and all showed notable improvements over AUC from traditional lung dose metrics (0.55). Identifying the combinations most predictive of grade 3+ RP provides valuable data to inform the functional-guided radiation therapy process.

Citing Articles

Patient-Reported Outcomes: Comparing Functional Avoidance and Standard Thoracic Radiation Therapy in Lung Cancer.

Poiset S, Lombardo J, Castillo E, Castillo R, Jones B, Miften M JCO Clin Cancer Inform. 2025; 9:e2400202.

PMID: 39903899 PMC: 11801246. DOI: 10.1200/CCI-24-00202.


A review on functional lung avoidance radiotherapy plan for lung cancer.

Yu J, Tang X, Lei Y, Zhang Z, Li B, Bai H Front Oncol. 2024; 14:1429837.

PMID: 39703855 PMC: 11656049. DOI: 10.3389/fonc.2024.1429837.


Advances in CT-based lung function imaging for thoracic radiotherapy.

Bi S, Yuan Q, Dai Z, Sun X, Wan Sohaimi W, Bin Yusoff A Front Oncol. 2024; 14:1414337.

PMID: 39286020 PMC: 11403405. DOI: 10.3389/fonc.2024.1414337.


Incorporation of Functional Lung Imaging Into Radiation Therapy Planning in Patients With Lung Cancer: A Systematic Review and Meta-Analysis.

Midroni J, Salunkhe R, Liu Z, Chow R, Boldt G, Palma D Int J Radiat Oncol Biol Phys. 2024; 120(2):370-408.

PMID: 38631538 PMC: 11580018. DOI: 10.1016/j.ijrobp.2024.04.001.


Prospective Trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report.

Lombardo J, Castillo E, Castillo R, Miller R, Jones B, Miften M Int J Radiat Oncol Biol Phys. 2024; 120(2):593-602.

PMID: 38614278 PMC: 11381170. DOI: 10.1016/j.ijrobp.2024.03.046.


References
1.
Du K, Bayouth J, Cao K, Christensen G, Ding K, Reinhardt J . Reproducibility of registration-based measures of lung tissue expansion. Med Phys. 2012; 39(3):1595-608. PMC: 3306443. DOI: 10.1118/1.3685589. View

2.
Seppenwoolde Y, De Jaeger K, Boersma L, Belderbos J, Lebesque J . Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004; 60(3):748-58. DOI: 10.1016/j.ijrobp.2004.04.037. View

3.
Lavrenkov K, Christian J, Partridge M, Niotsikou E, Cook G, Parker M . A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol. 2007; 83(2):156-62. DOI: 10.1016/j.radonc.2007.04.005. View

4.
Yaremko B, Guerrero T, Noyola-Martinez J, Guerra R, Lege D, Nguyen L . Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance. Int J Radiat Oncol Biol Phys. 2007; 68(2):562-71. PMC: 3490190. DOI: 10.1016/j.ijrobp.2007.01.044. View

5.
Miften M, Das S, Su M, Marks L . Incorporation of functional imaging data in the evaluation of dose distributions using the generalized concept of equivalent uniform dose. Phys Med Biol. 2004; 49(9):1711-21. DOI: 10.1088/0031-9155/49/9/009. View